{"id":1006628,"date":"2026-09-29T10:54:10","date_gmt":"2026-09-29T14:54:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/"},"modified":"2026-09-29T10:54:10","modified_gmt":"2026-09-29T14:54:10","slug":"celularity-announces-naveen-jain-to-join-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/","title":{"rendered":"Celularity Announces Naveen Jain to Join Board of Directors"},"content":{"rendered":"<h2>\nViome founder and CEO brings a consumer-focused vision for bringing regenerative therapies to more people and advancing proactive health<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>FLORHAM PARK, N.J., Sept.  29, 2026  (GLOBE NEWSWIRE) &#8212; Celularity Inc. (Nasdaq: CELU) (\u201cCelularity\u201d or the \u201cCompany\u201d), a regenerative medicine company, today announced that Naveen Jain, founder and Chief Executive Officer of Viome Life Sciences Inc. (\u201cViome\u201d), will join its Board of Directors.<\/p>\n<p>Jain founded InfoSpace, Intelius, TalentWise and Moon Express and is the founder and CEO of Viome, which applies AI and molecular data to personalized health and nutrition. He joins Celularity\u2019s Board with a consumer-focused perspective on healthcare\u2019s shift from treating illness to helping people take a more proactive role in their health. He will bring that perspective to the challenge of bringing promising regenerative therapies to more consumers.<\/p>\n<p>\u201cNaveen has devoted considerable energy to the pursuit of longer, healthier lives, and shares our belief in the significant potential of regenerative longevity,\u201d said Robert J. Hariri, M.D., Ph.D., Chairman and Chief Executive Officer of Celularity. \u201cHe has a track record of pursuing ambitious ideas and building businesses around emerging technologies. That perspective will be valuable as we work to expand the commercial reach of Celularity\u2019s products and capabilities and explore the broader opportunities at the intersection of regenerative medicine and longevity.\u201d<\/p>\n<p>\u201cHealthcare is shifting from treating illness after symptoms appear to helping people take a more proactive role in their health. Regenerative medicine has the potential to be an important part of that shift. I\u2019m joining Celularity\u2019s Board to help translate that potential into real-world impact, bringing a consumer perspective, commercial discipline and partnerships to the work of bringing these therapies to more people,\u201d said Naveen Jain.<\/p>\n<p>\u201cNaveen brings a perspective that is crucial to what we are building around the boardroom,\u201d said fellow Board member, Philip A. Barach. \u201cWe have made meaningful progress strengthening Celularity\u2019s capital structure and operating profile. The opportunity now is to pair that discipline with an ambitious commercial vision for the assets the Company has already created.\u201d<\/p>\n<p>Mr. Jain joins the Company\u2019s newly constituted Board consisting of Dr. Hariri, Peter H. Diamandis, M.D., and Mr. Barach, who recently joined the Board as part of Celularity\u2019s broader recapitalization and strategic repositioning. Celularity expects to announce a fifth director shortly. Mr. Jain\u2019s appointment to the Board will become effective following completion of the applicable Rule 14f-1 information statement process.<\/p>\n<p>\n        <strong>About Naveen Jain<\/strong>\n      <\/p>\n<p>From personalized health to space exploration, Naveen Jain has built companies around questions with world-scale stakes. He is the founder and CEO of Viome Life Sciences, where AI and molecular data are applied to personalized health and nutrition. He previously founded InfoSpace, Intelius and TalentWise, and also founded Moon Express. Across technology, health and space, Jain has pursued a singular entrepreneurial vision: turn emerging technologies into new ways to address humanity\u2019s biggest challenges.<\/p>\n<p>\n        <strong>About Celularity<\/strong>\n      <\/p>\n<p>Celularity Inc. (Nasdaq: CELU) is a longevity-focused regenerative and cellular medicine company developing and manufacturing allogeneic and autologous cell therapies derived from the postpartum placenta. Celularity draws on the placenta\u2019s unique biology, immunologic properties and scalable availability to develop therapeutic solutions targeting fundamental mechanisms of aging and age-related disease. Its cellular therapy portfolio includes cenplacel-L, its investigational placenta-derived allogeneic cell therapy, and other investigational cellular therapies. Celularity is headquartered in Florham Park, New Jersey, where it operates a purpose-built cGMP research and manufacturing facility supporting the development and manufacture of cellular therapies, advanced biomaterials and other longevity and wellness-focused products.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S90zx77tcRaPcqtuy7yfE-l09b3MQeA9ukcFIIjMzNv4f7v1DJ2ZjqtSlS7Dnz0Vhxp2kh6IlBoUzbvKe5lPu6XGo_PeMwF_OzE9-R9GGNg=\" rel=\"nofollow\" target=\"_blank\">www.celularity.com<\/a>.<\/p>\n<p>\n        <strong>Forward Looking Statements<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding Mr. Jain\u2019s anticipated appointment to and contributions as a member of the Company\u2019s Board of Directors; the Company\u2019s strategy to expand the commercial reach of its products and capabilities; the potential for regenerative medicine and the Company\u2019s technologies to address aging and age-related disease and contribute to more proactive approaches to health; the Company\u2019s ability to translate its technologies into commercial opportunities, expand access to its products and develop strategic partnerships; and the expected appointment of an additional director.<\/p>\n<p>These forward-looking statements are based on management\u2019s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including risks relating to regulatory requirements and approvals, clinical development, manufacturing, commercialization and market acceptance, the Company\u2019s ability to execute its business strategy and obtain sufficient financing, and the other risks and uncertainties described in the Company\u2019s filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Celularity undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.<\/p>\n<p>\n        <strong>Investor and Media Contact<\/strong>:<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lW0wBna-ATUvBDL4Y7sm7VU-7EuQQYZTKwFMrvD4qxde5_3Ip9mGQPIEtNzirURQ8eL4qvhHrZx4T-I_7OotYmELyMzMlSOCGQ47mc3S21A=\" rel=\"nofollow\" target=\"_blank\">info@celularity.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWM0NGZjMWMtZjRmNy00MDMwLTllMDctMjM4NDM3OWFjN2Q3LTEyMTY1NjItMjAyNi0wOS0yOS1lbg==\/tiny\/Celularity-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Viome founder and CEO brings a consumer-focused vision for bringing regenerative therapies to more people and advancing proactive health FLORHAM PARK, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Celularity Inc. (Nasdaq: CELU) (\u201cCelularity\u201d or the \u201cCompany\u201d), a regenerative medicine company, today announced that Naveen Jain, founder and Chief Executive Officer of Viome Life Sciences Inc. (\u201cViome\u201d), will join its Board of Directors. Jain founded InfoSpace, Intelius, TalentWise and Moon Express and is the founder and CEO of Viome, which applies AI and molecular data to personalized health and nutrition. He joins Celularity\u2019s Board with a consumer-focused perspective on healthcare\u2019s shift from treating illness to helping people take a more proactive role in their health. He will bring that perspective to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Celularity Announces Naveen Jain to Join Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1006628","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celularity Announces Naveen Jain to Join Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celularity Announces Naveen Jain to Join Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Viome founder and CEO brings a consumer-focused vision for bringing regenerative therapies to more people and advancing proactive health FLORHAM PARK, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Celularity Inc. (Nasdaq: CELU) (\u201cCelularity\u201d or the \u201cCompany\u201d), a regenerative medicine company, today announced that Naveen Jain, founder and Chief Executive Officer of Viome Life Sciences Inc. (\u201cViome\u201d), will join its Board of Directors. Jain founded InfoSpace, Intelius, TalentWise and Moon Express and is the founder and CEO of Viome, which applies AI and molecular data to personalized health and nutrition. He joins Celularity\u2019s Board with a consumer-focused perspective on healthcare\u2019s shift from treating illness to helping people take a more proactive role in their health. He will bring that perspective to &hellip; Continue reading &quot;Celularity Announces Naveen Jain to Join Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-29T14:54:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Celularity Announces Naveen Jain to Join Board of Directors\",\"datePublished\":\"2026-09-29T14:54:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/\"},\"wordCount\":825,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/\",\"name\":\"Celularity Announces Naveen Jain to Join Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=\",\"datePublished\":\"2026-09-29T14:54:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-announces-naveen-jain-to-join-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celularity Announces Naveen Jain to Join Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celularity Announces Naveen Jain to Join Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Celularity Announces Naveen Jain to Join Board of Directors - Market Newsdesk","og_description":"Viome founder and CEO brings a consumer-focused vision for bringing regenerative therapies to more people and advancing proactive health FLORHAM PARK, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Celularity Inc. (Nasdaq: CELU) (\u201cCelularity\u201d or the \u201cCompany\u201d), a regenerative medicine company, today announced that Naveen Jain, founder and Chief Executive Officer of Viome Life Sciences Inc. (\u201cViome\u201d), will join its Board of Directors. Jain founded InfoSpace, Intelius, TalentWise and Moon Express and is the founder and CEO of Viome, which applies AI and molecular data to personalized health and nutrition. He joins Celularity\u2019s Board with a consumer-focused perspective on healthcare\u2019s shift from treating illness to helping people take a more proactive role in their health. He will bring that perspective to &hellip; Continue reading \"Celularity Announces Naveen Jain to Join Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-29T14:54:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Celularity Announces Naveen Jain to Join Board of Directors","datePublished":"2026-09-29T14:54:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/"},"wordCount":825,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/","name":"Celularity Announces Naveen Jain to Join Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=","datePublished":"2026-09-29T14:54:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTY1NSM3ODY4MzUyIzIyMDUwMDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-announces-naveen-jain-to-join-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Celularity Announces Naveen Jain to Join Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1006628"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006628\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1006628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1006628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1006628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}